This innovative swabbing compound is generating a very performant mould lubrication and leaving glass well finished and clean. Carbon deposits and emissions are reduced to a minimum and reaching levels much lower than traditional swabbing compounds.
Glassline® SwabPharma-I has been tested & approved on borosilicate pharmaceutical glass Type-I.
Oil mist produced after swabbing of heated mould is considerably reduced to avoid operator exposition to dangerous emissions. Additionally, emissions such as PAH – Polycyclic Aromatic Hydrocarbons have been decreased by more than 80%.
Glassline® SwabPharma does not contain ingredients of animal origin, such as fatty acids from lard oil.